Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Parry

Showing results (91-100 of 199) with videos related to

Pageof 20
Sort By:
Journal of Medical Virology|January 1, 1995
GACPAT HIV 1 + 2: a simple, inexpensive assay to screen for, and discriminate between, anti-HIV 1 and anti-HIV 2J V Parry, J A Connell, P Reinbott, et al.
Neurosurgery|October 17, 2009
Importance of the C1 anterior tubercle depth and lateral mass geometry when placing C1 lateral mass screwsScott D Wait, Francisco A Ponce, Kyle O Colle, et al.
AIDS (London, England)|May 1, 1991
Prevalence of HIV, hepatitis B and associated risk behaviours in clients of a needle-exchange in central LondonG J Hart, N Woodward, A M Johnson, et al.
AIDS (London, England)|May 1, 1989
Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one yearG J Hart, A L Carvell, N Woodward, et al.
Progress in Neurological Surgery|January 13, 2012
Future perspectives on brain metastasis managementEdward A Monaco Iii, Phillip V Parry, Ramesh Grandhi, et al.
BMJ (Clinical Research Ed.)|November 24, 2001
Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional surveyJ Long, S Allwright, J Barry, et al.
Organic & Biomolecular Chemistry|September 29, 2011
Small molecule inhibitors that discriminate between protein arginine N-methyltransferases PRMT1 and CARM1James Dowden, Richard A Pike, Richard V Parry, et al.
Epidemiology and Infection|August 1, 2019
Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the UK?J Njoroge, V D Hope, C O'Halloran, et al.
Communicable Disease and Public Health|July 21, 2000
Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national surveyA R Weild, O N Gill, D Bennett, et al.
European Journal of Immunology|November 22, 1997
Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase BR V Parry, K Reif, G Smith, et al.
Pageof 20

Showing results (91-100 of 199) with videos related to

Sort By:
Pageof 20
Journal of Medical Virology|January 1, 1995
GACPAT HIV 1 + 2: a simple, inexpensive assay to screen for, and discriminate between, anti-HIV 1 and anti-HIV 2J V Parry, J A Connell, P Reinbott, et al.
Neurosurgery|October 17, 2009
Importance of the C1 anterior tubercle depth and lateral mass geometry when placing C1 lateral mass screwsScott D Wait, Francisco A Ponce, Kyle O Colle, et al.
AIDS (London, England)|May 1, 1991
Prevalence of HIV, hepatitis B and associated risk behaviours in clients of a needle-exchange in central LondonG J Hart, N Woodward, A M Johnson, et al.
AIDS (London, England)|May 1, 1989
Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one yearG J Hart, A L Carvell, N Woodward, et al.
Progress in Neurological Surgery|January 13, 2012
Future perspectives on brain metastasis managementEdward A Monaco Iii, Phillip V Parry, Ramesh Grandhi, et al.
BMJ (Clinical Research Ed.)|November 24, 2001
Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional surveyJ Long, S Allwright, J Barry, et al.
Organic & Biomolecular Chemistry|September 29, 2011
Small molecule inhibitors that discriminate between protein arginine N-methyltransferases PRMT1 and CARM1James Dowden, Richard A Pike, Richard V Parry, et al.
Epidemiology and Infection|August 1, 2019
Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the UK?J Njoroge, V D Hope, C O'Halloran, et al.
Communicable Disease and Public Health|July 21, 2000
Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national surveyA R Weild, O N Gill, D Bennett, et al.
European Journal of Immunology|November 22, 1997
Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase BR V Parry, K Reif, G Smith, et al.
Pageof 20